Amyris, Inc., a vertically integrated biomanufacturing company based in Emeryville, Calif., has announced that it will acquire Oobli Inc., a Davis, Calif.-based sweet protein innovator whose fermentation-based ingredients are designed to help food and beverage brands reduce sugar without sacrificing taste.
Amyris said the acquisition combines its scientific capabilities and manufacturing depth with Oobli’s protein fermentation expertise. The move follows Amyris’ expansion of manufacturing capacity earlier this year at its advanced fermentation facility in Barra Bonita, Brazil. Amyris described the deal as a strategic commercial and technology expansion that would accelerate its footprint in protein- and peptide-based solutions across end markets.
Complementary capabilities
“In Oobli, we see a commercial and technology platform that is a great complement to our own,” Amyris Chief Executive Officer Kathy Fortmann said in the announcement. She said Oobli is positioned to change how sweetness reaches the market and that Amyris intends to contribute commercial scale and resources to accelerate that effort.
Fortmann also said that combining Oobli’s protein expertise with Amyris’ strain engineering, manufacturing scale and commercial capabilities could broaden the company’s work in food and beverage, personal care, flavor and fragrance, agriculture and other areas.
Sweet protein portfolio
Oobli’s commercial portfolio of sweet proteins is expected to be the first to benefit from the combined platform. According to the announcement, Oobli has spent the past decade refining a fermentation process for producing sweet proteins naturally found in rare fruits and berries near the equator. Oobli describes its sweet proteins as the first of their kind in the sugar-reduction category.
According to Oobli, sweet proteins are hundreds to thousands of times sweeter than sugar, bind directly to sweet taste receptors and are metabolized by the body as protein. The company says they deliver sweetness without gut disruption or blood sugar spikes. These are company claims about the ingredients; the announcement did not provide independent study results.
The portfolio includes Oubli Fruit, Serendipity Berry and Katemfe Fruit Sweet Proteins, scientifically known as brazzein, monellin and thaumatin, respectively. Oobli says the ingredients have FDA GRAS status and are FEMA GRAS-affirmed for use as a natural flavor. The company points to growing consumer awareness of metabolic health and sugar reduction, saying sweet proteins can give brands a tool to cut sugar in categories including sports nutrition, dairy, beverages, chocolate, bakery and confectionery.
Leadership views and closing
Oobli Chief Executive Officer Ali Wing said the company has long believed there was a better way to deliver the sweet taste consumers want without trade-offs to health and the environment. She said joining Amyris would give Oobli the scale and resources to pursue its ambition of making sweet proteins a global standard in sweetness solutions.
Fortmann added that biomanufactured solutions succeed when they align with consumer demand and market needs, and she said Oobli’s platform does that by offering brands a way to address sweet taste, sugar reduction and clean label at the same time.
The acquisition is expected to close in the coming weeks. The announcement said that as Oobli’s sweet protein portfolio expands within Amyris, existing customer commitments and brand partnerships will continue to be honored uninterrupted.
